
MPT Stock Forecast & Price Target
MPT Analyst Ratings
Bulls say
Medical Properties Trust is viewed favorably because its long-term, net-leased healthcare portfolio can benefit from a rebound in hospital operating conditions and tenant coverage, which would strengthen rent collection and improve the durability of cash flows. The analysis also points to meaningful embedded asset value, with in-place NAV estimated at $2.14/share and potential to rise to $2.77/share at YE26E and $4.00/share at YE27E if underperforming assets and former Steward, Prospect, and Priory properties recover value. In addition, monetizing zero- or under-earning properties and refinancing $587 million of 2026 debt and $1.6 billion of 2027 debt could reduce balance-sheet pressure and unlock upside.
Bears say
Medical Properties Trust is facing a fundamentally कमजोर outlook because tenant distress, especially at HSA and Priory, is pressuring rent collections and forcing lease restructuring, while rent recovery remains uncertain and near-term working capital support may not be repaid quickly. Its earnings power is also being diluted by expensive refinancing, as $2.4 billion of secured debt at 9.25% replaced bonds yielding about 3.7%, and estimates were cut to $0.44/share in 2026, $0.27/share in 2027, and $0.26/share in 2028. With only about $216 million of cash net of LOC balances against $94 million of committed developments and an estimated cash burn rate of roughly $160 million in 2027 and 2028, elevated leverage and tight liquidity leave little margin for error.
This aggregate rating is based on analysts' research of Medical Properties Trust Inc and is not a guaranteed prediction by Public.com or investment advice.
MPT Analyst Forecast & Price Prediction
Start investing in MPT
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Medical Properties Trust Inc (MPT) Forecast
MPT Analyst Forecast & Price Prediction
Start investing in MPT
Order type
Buy in
Order amount
Est. shares
0 shares